Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 440

1.

An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes.

Levet S, Medina J, Joanou J, Demolder A, Queruel N, Réant K, Normand M, Seffals M, Dimier J, Germi R, Piofczyk T, Portoukalian J, Touraine JL, Perron H.

JCI Insight. 2017 Sep 7;2(17). pii: 94387. doi: 10.1172/jci.insight.94387. eCollection 2017 Sep 7.

2.

First international workshop on human endogenous retroviruses and diseases, HERVs & disease 2015.

Nath A, Küry P, Sciascia do Olival G, Dolei A, Karlsson H, Groc L, Schneider M, Kriesel J, Touraine JL, Mallet F, Marche PN, Arnaud F, Feschotte C, Perron H.

Mob DNA. 2015 Oct 15;6:20. doi: 10.1186/s13100-015-0051-7. eCollection 2015.

3.

Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.

Perron H, Dougier-Reynaud HL, Lomparski C, Popa I, Firouzi R, Bertrand JB, Marusic S, Portoukalian J, Jouvin-Marche E, Villiers CL, Touraine JL, Marche PN.

PLoS One. 2013 Dec 6;8(12):e80128. doi: 10.1371/journal.pone.0080128. eCollection 2013.

4.

Prope tolerance to heart allografts in mice associated with persistence of donor interleukin-10-transduced stem cells.

Brikci-Nigassa L, Matsuyama M, Hase T, Eljaafari A, Chargui J, Sanhadji K, Inori F, Nakatani T, Yoshimura R, Touraine JL.

Transplantation. 2012 Apr 27;93(8):761-8. doi: 10.1097/TP.0b013e318248372b.

PMID:
22487811
5.

First presentation for care of HIV-infected patients with low CD4 cell count in Lyon, France: risk factors and consequences for survival.

Touré A, Khanafer N, Baratin D, Bailly F, Livrozet JM, Trepo C, Peyramond D, Touraine JL, Vanhems P.

AIDS Care. 2012;24(10):1272-6. doi: 10.1080/09540121.2012.656574. Epub 2012 Mar 15.

PMID:
22416893
6.

Transplantation tolerance induced in humans at the fetal or the neonatal stage.

Touraine JL, Sanhadji K.

J Transplant. 2011;2011:760319. doi: 10.1155/2011/760319. Epub 2011 Aug 18.

7.

High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.

Benzaïd I, Mönkkönen H, Stresing V, Bonnelye E, Green J, Mönkkönen J, Touraine JL, Clézardin P.

Cancer Res. 2011 Jul 1;71(13):4562-72. doi: 10.1158/0008-5472.CAN-10-3862. Epub 2011 Jun 6.

8.

Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model.

Matsuyama M, Yoshimura R, Hase T, Chargui J, Yoshimura N, Touraine JL.

Mol Med Rep. 2010 Sep-Oct;3(5):771-4. doi: 10.3892/mmr.2010.339. Epub 2010 Jul 26.

PMID:
21472312
9.

Expression of sphingosine-1 phosphate receptor in rat renal ischemia-reperfusion injury.

Matsuyama M, Funao K, Kuratsukuri K, Tanaka T, Kawahito Y, Sano H, Chargui J, Touraine JL, Yoshimura N, Yoshimura R.

Mol Med Rep. 2010 Mar-Apr;3(2):233-6. doi: 10.3892/mmr_00000245.

PMID:
21472227
10.

HIV-1 infection: functional competition between gp41 and interleukin-2.

Sanhadji K, Tardy JC, Touraine JL.

C R Biol. 2010 Aug;333(8):608-12. doi: 10.1016/j.crvi.2009.01.009. Epub 2010 Jun 23.

PMID:
20688281
11.

Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient.

Brodin-Sartorius A, Mekki Y, Pastural M, Billaud G, Daoud S, Chauvet C, Touraine JL, Lina B, Morelon E, Thaunat O.

Transpl Infect Dis. 2011 Feb;13(1):97-8. doi: 10.1111/j.1399-3062.2010.00546.x. No abstract available.

PMID:
20636481
12.

Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus vs cyclosporine.

Morelon E, Lefrançois N, Besson C, Prévautel J, Brunet M, Touraine JL, Badet L, Touraine-Moulin F, Thaunat O, Malcus C.

Transpl Immunol. 2010 May;23(1-2):53-8. doi: 10.1016/j.trim.2010.04.004. Epub 2010 Apr 18.

PMID:
20406686
13.

Telmisartan inhibits human urological cancer cell growth through early apoptosis.

Matsuyama M, Funao K, Kuratsukuri K, Tanaka T, Kawahito Y, Sano H, Chargui J, Touraine JL, Yoshimura N, Yoshimura R.

Exp Ther Med. 2010 Mar;1(2):301-306. Epub 2010 Mar 1.

14.

Kidney transplant and cryptic hepatitis.

Chaubo C, Hot A, Chevallier-Queyron P, Ritter J, Scoazec JY, Zoulim F, Karamé A, Brunet M, Touraine JL, Morelon E.

Lancet. 2009 Jun 13;373(9680):2082. doi: 10.1016/S0140-6736(09)60739-X. No abstract available.

PMID:
19524783
15.

The role of the transplant physician in the management of skin cancers after organ transplantation.

Morelon E, Mahe E, Touraine JL.

Cancer Treat Res. 2009;146:377-90. doi: 10.1007/978-0-387-78574-5_30. Review. No abstract available.

PMID:
19415217
16.

The role of cysteinyl-LT(1)receptor (CysLT(1)R) in renal ischemia-reperfusion injury.

Matsuyama M, Funao K, Chargui J, Touraine JL, Nakatani T, Yoshimura R.

Transplant Proc. 2009 Jan-Feb;41(1):73-5. doi: 10.1016/j.transproceed.2008.08.153.

PMID:
19249480
17.

Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma.

Funao K, Matsuyama M, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T, Yoshimura R.

Mol Med Rep. 2009 Mar-Apr;2(2):193-8. doi: 10.3892/mmr_00000083.

PMID:
21475812
18.

Expression of cysteinylLT1 receptor in human testicular cancer and growth reduction by its antagonist through apoptosis.

Matsuyama M, Funao K, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T, Yoshimura R.

Mol Med Rep. 2009 Mar-Apr;2(2):163-7. doi: 10.3892/mmr_00000078.

PMID:
21475807
19.

Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells.

Bennaceur K, Popa I, Chapman JA, Migdal C, Péguet-Navarro J, Touraine JL, Portoukalian J.

Glycobiology. 2009 Jun;19(6):576-82. doi: 10.1093/glycob/cwp015. Epub 2009 Feb 24.

20.

Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation.

Thaunat O, Hanf W, Dubois V, McGregor B, Perrat G, Chauvet C, Touraine JL, Morelon E.

Transpl Immunol. 2009 Mar;20(4):209-11. doi: 10.1016/j.trim.2008.12.006. Epub 2009 Jan 21.

PMID:
19166936
21.

Study of cysteinyl leukotriene-1 receptor in rat renal ischemia-reperfusion injury.

Matsuyama M, Funao K, Kawahito Y, Sano H, Chargui J, Touraine JL, Takemoto Y, Nakatani T, Yoshimura R.

Transplant Proc. 2008 Sep;40(7):2149-51. doi: 10.1016/j.transproceed.2008.06.009.

PMID:
18790177
22.

Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.

Voirin N, Routy JP, Smith D, Baratin D, Trépo C, Cotte L, Touraine JL, Livrozet JM, Cooper DA, Ritter J, André P, Vanhems P.

HIV Med. 2008 Jul;9(6):440-4. doi: 10.1111/j.1468-1293.2008.00576.x.

23.

Immunosuppressive networks in the tumour environment and their effect in dendritic cells.

Bennaceur K, Chapman JA, Touraine JL, Portoukalian J.

Biochim Biophys Acta. 2009 Jan;1795(1):16-24. doi: 10.1016/j.bbcan.2008.07.001. Epub 2008 Jul 15. Review. Retraction in: Biochim Biophys Acta. 2013 Apr;1835(2):259.

PMID:
18675885
24.

Telmisartan is a potent target for prevention and treatment in human prostate cancer.

Funao K, Matsuyama M, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T, Yoshimura R.

Oncol Rep. 2008 Aug;20(2):295-300.

PMID:
18636189
25.

Dendritic cells dysfunction in tumour environment.

Bennaceur K, Chapman J, Brikci-Nigassa L, Sanhadji K, Touraine JL, Portoukalian J.

Cancer Lett. 2008 Dec 18;272(2):186-96. doi: 10.1016/j.canlet.2008.05.017. Epub 2008 Jun 27. Review.

PMID:
18585853
26.

Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury.

Matsuyama M, Yoshimura R, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T.

Mol Med Rep. 2008 Jul-Aug;1(4):499-503.

PMID:
21479439
27.

The role of arachidonic acid in a rat renal ischemia-reperfusion injury model.

Matsuyama M, Yoshimura R, Funao K, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T.

Mol Med Rep. 2008 Jul-Aug;1(4):493-7.

PMID:
21479438
28.

The effect of neutrophil elastase inhibitor on acute tubular necrosis after renal ischemia-reperfusion injury.

Matsuyama M, Hayama T, Funao K, Naganuma T, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T, Yoshimura R.

Mol Med Rep. 2008 Jul-Aug;1(4):489-92.

PMID:
21479437
29.

Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods.

Saindou M, Chidiac C, Miailhes P, Voirin N, Baratin D, Amiri M, Livrozet JM, Touraine JL, Trepo C, Peyramond D, Vanhems P.

HIV Med. 2008 Apr;9(4):203-7. doi: 10.1111/j.1468-1293.2008.00546.x. Epub 2008 Feb 21.

30.

[Infectious complications due to immunosuppression in organ transplant patients].

Morelon E, Touraine JL.

Rev Prat. 2007 Oct 15;57(15):1677-86. French.

PMID:
18080426
31.

Immunological lessons learnt from patients transplanted with fully mismatched stem cells.

Touraine JL, Plotnicky H, Roncarolo MG, Bacchetta R, Gebuhrer L.

Immunol Res. 2007;38(1-3):201-9.

PMID:
17917026
32.

Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort.

Bénet T, D'Oliveira A Jr, Voirin N, Livrozet JM, Cotte L, Peyramond D, Chidiac C, Touraine JL, Fabry J, Trepo C, Allard R, Vanhems P.

J Viral Hepat. 2007 Oct;14(10):730-5.

PMID:
17875008
33.

Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.

Euvrard S, Kanitakis J, Decullier E, Butnaru AC, Lefrançois N, Boissonnat P, Sebbag L, Garnier JL, Pouteil-Noble C, Cahen R, Morelon E, Touraine JL, Claudy A, Chapuis F.

Transplantation. 2006 Apr 27;81(8):1093-100.

PMID:
16641592
34.

[Kaposi's sarcoma and organ transplantation: 22 cases].

Bécuwe C, Euvrard S, Bosshard S, Pouteil-Noble C, Garnier JL, Lefrançois N, Boillot O, Kanitakis J, Touraine JL, Claudy A.

Ann Dermatol Venereol. 2005 Nov;132(11 Pt 1):839-43. French.

PMID:
16327712
35.

A recent increase in AIDS at Lyon University Hospitals: patient characteristics and comparisons with previous years.

Baratin D, Marceillac E, Trepo C, Cotte L, Peyramond D, Chidiac C, Touraine JL, Livrozet JM, Fabry J, Vanhems P.

HIV Med. 2006 Jan;7(1):59-63.

36.

Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992-2002.

D'Oliveira A Jr, Voirin N, Allard R, Peyramond D, Chidiac C, Touraine JL, Fabry J, Trepo C, Vanhems P.

J Viral Hepat. 2005 May;12(3):330-2.

PMID:
15850476
37.

Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.

Hase T, Chargui J, Inori F, Yoshimura R, Sembeil R, Nakatani T, Touraine JL.

Transplant Proc. 2005 Jan-Feb;37(1):287-8.

PMID:
15808621
38.

Induction of transplantation tolerance in humans using fetal cell transplants.

Touraine JL, Roncarolo MG, Raudrant D, Bacchetta R, Golfier F, Sembeil R, Gebuhrer L.

Transplant Proc. 2005 Jan-Feb;37(1):65-6.

PMID:
15808548
39.

The incidence of herpes zoster is less likely than other opportunistic infections to be reduced by highly active antiretroviral therapy.

Vanhems P, Voisin L, Gayet-Ageron A, Trepo C, Cotte L, Peyramond D, Chidiac C, Touraine JL, Livrozet JM, Fabry J, Voirin N.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):111-3. No abstract available.

PMID:
15608535
40.

Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients.

Rabodonirina M, Vanhems P, Couray-Targe S, Gillibert RP, Ganne C, Nizard N, Colin C, Fabry J, Touraine JL, van Melle G, Nahimana A, Francioli P, Hauser PM.

Emerg Infect Dis. 2004 Oct;10(10):1766-73.

41.

Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.

Voirin N, Trépo C, Miailhes P, Touraine JL, Chidiac C, Peyramond D, Livrozet JM, Ritter J, Chevallier P, Fabry J, Allard R, Vanhems P.

J Viral Hepat. 2004 Nov;11(6):559-62.

PMID:
15500557
42.

Characteristics of patients diagnosed with AIDS shortly after first detection of HIV antibodies in Lyon University hospitals from 1985 to 2001.

Baratin D, Marceillac E, Trepo C, Cotte L, Peyramond D, Chidiac C, Touraine JL, Livrozet JM, Fabry J, Allard R, Vanhems P.

HIV Med. 2004 Jul;5(4):273-7.

43.

Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.

Sembeil R, Sanhadji K, Vivier G, Chargui J, Touraine JL.

Transpl Immunol. 2004 Jun-Jul;13(1):1-8.

PMID:
15203122
44.

Reappraisal of in utero stem cell transplantation based on long-term results.

Touraine JL, Raudrant D, Golfier F, Rebaud A, Sembeil R, Roncarolo MG, Bacchetta R, D'Oiron R, Lambert T, Gebuhrer L.

Fetal Diagn Ther. 2004 Jul-Aug;19(4):305-12. Review.

PMID:
15192288
45.

The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000.

Gayet-Ageron A, Baratin D, Marceillac E, Allard R, Peyramond D, Chidiac C, Trepo C, Livrozet JM, Touraine JL, Ritter J, Sepetjan M, Fabry J, Vanhems P.

HIV Med. 2004 May;5(3):163-70.

46.

Gene therapy for human immunodeficiency virus infection in the humanized SCID mouse model.

Touraine JL, Sanhadji K, Sembeil R.

Isr Med Assoc J. 2003 Dec;5(12):863-7.

47.

The recent increase of syphilis cases in Lyon University hospitals Is mainly observed in HIV-infected patients: descriptive data from a laboratory-based surveillance system.

Giard M, Queyron PC, Ritter J, Peyramond D, Trépo C, Miailhes P, Chidiac C, Touraine JL, Livrozet JM, Boibieux A, Fabry J, Allard R, Vanhems P.

J Acquir Immune Defic Syndr. 2003 Dec 1;34(4):441-3. No abstract available.

PMID:
14615665
48.

Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study.

Charpentier B, Groth CG, Bäckman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattström C; Sirolimus European Renal Transplant Study.

Transplant Proc. 2003 May;35(3 Suppl):58S-61S.

PMID:
12742468
49.

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients.

Charpentier B, Rostaing L, Berthoux F, Lang P, Civati G, Touraine JL, Squifflet JP, Vialtel P, Abramowicz D, Mourad G, Wolf P, Cassuto E, Moulin B, Rifle G, Pruna A, Merville P, Mignon F, Legendre C, Le Pogamp P, Lebranchu Y, Toupance O, Hurault De Ligny B, Touchard G, Olmer M, Purgus R, Pouteil-Noble C, Glotz D, Bourbigot B, Leski M, Wauters JP, Kessler M.

Transplantation. 2003 Mar 27;75(6):844-51.

PMID:
12660513
50.

Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation.

Harzallah K, Badid C, Fouque D, Lefrancois N, Touraine JL, Laville M.

Clin Nephrol. 2003 Mar;59(3):212-6.

PMID:
12653266

Supplemental Content

Loading ...
Support Center